Suppliers / Oxford Pharmaceuticals

Oxford Pharmaceuticals

United States 44 employees Updated 9 July 2026

Oxford Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 8 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and DMP (NO). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 3 November 2023 as VAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
8
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 3 November 2023 VAI US FDA
  • 8 June 2022 NAI US FDA
  • 22 May 2019 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Birmingham, United States 3012257735

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 7 1
DMP (NO) 1 None

Questions about Oxford Pharmaceuticals

Does Oxford Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Oxford Pharmaceuticals. It does have 8 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Oxford Pharmaceuticals FDA-registered?
One site operated by Oxford Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Oxford Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 3 November 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Oxford Pharmaceuticals manufacture?
1 registered site is on record, in United States (Birmingham). Every site is listed on this page with the register it came from.
Which regulators recognise Oxford Pharmaceuticals's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Oxford Pharmaceuticals?

Ask Fred what the record holds on Oxford Pharmaceuticals, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Open risk flags

  • The most recent inspection outcome was VAI, on 3 November 2023.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates